The SARS-CoV-2 responsible for phlegmasia cerulea dolens: a case report.
Autor: | Banana Y; Departments of Vascular Surgery., Bashir H; Departments of Vascular Surgery., Boukabous S; Nephrology - Dialysis and Kidney Transplantation, Mohammed VI University Hospital of Oujda., Haddiya I; Nephrology - Dialysis and Kidney Transplantation, Mohammed VI University Hospital of Oujda.; Laboratory of Epidemiology, Clinical Research and Public Health, Faculty of Medicine and Pharmacy, Mohammed the First University of Oujda, Oujda, Morocco., Bentata Y; Nephrology - Dialysis and Kidney Transplantation, Mohammed VI University Hospital of Oujda.; Laboratory of Epidemiology, Clinical Research and Public Health, Faculty of Medicine and Pharmacy, Mohammed the First University of Oujda, Oujda, Morocco., Rezziki A; Departments of Vascular Surgery.; Laboratory of Epidemiology, Clinical Research and Public Health, Faculty of Medicine and Pharmacy, Mohammed the First University of Oujda, Oujda, Morocco., Benzirar A; Departments of Vascular Surgery.; Laboratory of Epidemiology, Clinical Research and Public Health, Faculty of Medicine and Pharmacy, Mohammed the First University of Oujda, Oujda, Morocco., El Mahi O; Departments of Vascular Surgery.; Laboratory of Epidemiology, Clinical Research and Public Health, Faculty of Medicine and Pharmacy, Mohammed the First University of Oujda, Oujda, Morocco. |
---|---|
Jazyk: | angličtina |
Zdroj: | Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2023 Mar 24; Vol. 85 (3), pp. 485-487. Date of Electronic Publication: 2023 Mar 24 (Print Publication: 2023). |
DOI: | 10.1097/MS9.0000000000000152 |
Abstrakt: | Coronavirus disease 2019 (COVID-19) is a worldwide pandemic systemic infection that is responsible for serious coagulopathies similar to disseminated intravascular coagulation. Case Presentation: The authors report the case of a COVID-19 patient who presented with phlegmasia cerulea dolens (PCD) of the left lower limb, so he benefited from aponeurotomies of the internal and anterolateral muscular compartments. Clinical Discussion: The severe acute respiratory syndrome coronavirus 2 involves an inflammatory process in thrombotic events in COVID-19 patients, including a cytokine storm. PCD evolves in three semiological phases: venous stasis, weakening of the pulses, and the constitution of major ischemia. In the literature, the authors find many reports that have been published regarding increased thrombus formation in COVID-19 patients; these include DVT formation, pulmonary embolism, and stroke. Nevertheless, publications concerning PCD in COVID-19 patients remain rare. Conclusion: Although the severe acute respiratory syndrome coronavirus 2 remains a thrombogenic pathology, systematic anticoagulation is the subject of hypothesis. Hence the importance of regular monitoring of markers of vascular thrombosis. Competing Interests: There is no conflicts of interest between the authors.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. (Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.) |
Databáze: | MEDLINE |
Externí odkaz: |